Integris RRG Inc
Major Rating Factors:
Fair reserve development (3.6 on a scale of 0 to 10) as the level of reserves has at times been insufficient to cover claims. In 2022 and 2021 the two year reserve development was 28.2% and 50.6% deficient respectively. Fair overall results on stability tests (3.1) including weak risk adjusted capital in prior years and negative cash flow from operations for 2024. The largest net exposure for one risk is high at 4.9% of capital. Good overall profitability index (5.5) despite operating losses during 2020 and 2021. Return on equity has been fair, averaging 7.6% over the past five years.
Other Rating Factors:
Good liquidity (6.8) with sufficient resources (cash flows and marketable investments) to handle a spike in claims. Strong long-term capitalization index (7.3) based on excellent current risk adjusted capital (severe and moderate loss scenarios) reflecting significant improvement over results in 2021.
Stability Factors:
D - Limited diversification of general business, policy, and/or investment risk.
F - Negative cash flow.
T - Significant trends in critical asset, liability, income or expense items.
Principal Lines of Business:
Med mal (100.0%)
Licensed in:
DC
Principal Investments:
Investment grade bonds (64.3%), other (35.7%)
Ratios
Premium to Surplus
Reserve to Surplus
1-Year Reserve Development
2-Year Reserve Development
Expense Ratio
Combined Ratio
Cash From Underwriting
Net Premium Growth
Investments in Affiliates
--
Corporate Info
Group Affiliation
Integris Group Incorporated
Investment Rating
--
Company Address
80 Glastonbury Boulevard
Glastonbury, CT 06033
Glastonbury, CT 06033
Phone Number
(860) 633-7788
NAIC Number
13756
Largest Affiliates